| |
All subjects
|
Subjects with over LOD values
|
Subjects with over LOQ values
|
|---|
| |
CC
|
95% CI
|
CC
|
95% CI
|
CC
|
95% CI
|
|---|
|
PhIP intake
|
0.35
|
(0.11, 0.54)
|
0.21
|
(−0.05, 0.45)
|
0.34
|
(−0.07, 0.66)
|
|
MeIQ intake
|
0.36
|
(0.13, 0.56)
|
0.24
|
(−0.02, 0.47)
|
0.20
|
(−0.22, 0.56)
|
|
MeIQx intake
|
0.32
|
(0.08, 0.52)
|
0.24
|
(−0.02, 0.47)
|
0.17
|
(−0.25, 0.53)
|
|
Total HAA intake
|
0.34
|
(0.11, 0.54)
|
0.22
|
(−0.05, 0.45)
|
0.23
|
(−0.19, 0.58)
|
- CC correlation coefficient, CI confidence interval, HAA heterocyclic aromatic amine, LOD limit of detection, LOQ limit of quantification, MeIQ 2-amino-3,4-dimethylimidazo [4,5-f]quinoline, MeIQx 2-amino-3,8-dimethylimidazo [4,5-f]quinoxaline, PhIP 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine
- aData are from Iwasaki et al. [20]
